Partnering Webinars

  1. Unlocking Continued Revenue And Growth From Established Products 4/14/2025

    Gain insights into how pharmaceutical companies successfully handle post-approval regulatory upkeep for established products, focusing on reducing operational costs and expanding global market access.

  2. Critical Imaging Risks In GLP-1 And Neurology Studies 4/3/2025

    In the evolving landscape of GLP-1 and neurology clinical trials, imaging has become a pivotal tool for evaluating both efficacy and safety. Delve into the early indicators of imaging-related challenges and insights into preclinical strategies for effective risk mitigation.

  3. Elevating The Site Voice 3/27/2025

    A decentralized trial can be daunting for sites, but Medidata offers solutions to help site staff, sponsors, and patients move smoothly through the clinical trial process.

  4. Who's In Charge? How To Ensure Effective Trial Oversight, Leadership 3/19/2025

    Gain valuable insights into the role of sponsor-side Clinical Operations leadership, the risks of over-relying on CROs, and key strategies for fostering collaboration between sponsors and partners.

  5. Clinical Research Workforce Faces Growing Shortages 3/14/2025

    In this clip, Elisa Cascade of Advarra discusses a survey on the clinical research workforce found a 41% shortage of PIs across sites, with even greater shortages among CRCs. Nearly two-thirds reported staffing issues, threatening research sustainability. Most respondents believed the situation would worsen rather than improve, raising concerns about future workforce stability. 

  6. Financials Of Clinical Research Still A Deterrent To PIs 3/14/2025

    According to Jimmy Bechtel of SCRS, part of the one-and-done PI problem is the financials associated with clinical research.

  7. Is The BMIS Dataset Flawed For This Use? 3/14/2025

    The BMIS dataset, which tracks FDA Form 1572 submissions, is incomplete and voluntary, making it difficult to assess the true number of "one and done" PIs. Explore how past surveys have raised doubts about using the Form 1572 metric to measure retention of PIs. 

  8. CTTI Survey Identifies Why Many PIs Drop Out After One Trial 3/14/2025

    Morgan Hanger of CTTI discusses their survey of 201 PIs in FDA-regulated drug trials that indicated over half (108) participated only once in a trial, citing time constraints, workload, safety reporting, and financial burdens were why they did not continue. Despite these challenges, 44% wanted to continue but lacked opportunities, suggesting a disconnect in trial recruitment. 

  9. The Push To Understand PI Turnover/Retention 3/14/2025

    Harold Glass’ research highlighted subgroup differences among investigators, showing that even low-volume, less-experienced PIs expected to continue trials, often in co-investigator roles. Ken Getz of Tufts Center for the Study of Drug Development recognizes that Glass’ findings shaped further studies on turnover rates, with subsequent analyses deepening the understanding of investigator retention and the factors driving turnover in clinical research.

  10. Meeting Eye Exam Needs During The Pandemic And Beyond 3/11/2025

    Learn more about how mobile vision clinics supported the staff at trial sites as well as the patients through the COVID-19 pandemic and beyond.